Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensory perception comparison of two postoperative nasal sprays
2019-004936-52Phase 4Completed
- Sponsor
- Cassella-med
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of xylometazoline + dexpanthenol in nasal congestion (2 arms), sponsored by Cassella-med. Primary endpoint: Difference in nasal-spray-sensoric sum score after first application. Started Mar 2020; status: completed.
02
Drugs
xylometazoline + dexpanthenol
03
Conditions
nasal congestion
Beyond the preview
Go deeper on 2019-004936-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004936-52.